Page 4 - Preclinical Data News Today

12.08.2022 - Cash runway expected to extend from 2024 into 2025 upon completion of anticipated sale-leaseback of Tarzana, CA manufacturing site DELTA-1 trial of ITIL-168 in advanced melanoma with registrational intent anticipated to complete enrollment in 1H ...

Kinarus AG / Key word(s): Patent Positive Preclinical Data for KIN001 in wet Age-Related Macular Degeneration - Plans for Clinical Development 10.05.2022 / 09:45 MEDIA RELEASE (PDF) KIN001 reduced formation of leaky blood vessels and reduced retinal fibrosis in preclinical models of wet Age-Rela...

28.04.2022 - Seagen Inc. (Nasdaq:SGEN) reported financial results today for the first quarter ended March 31, 2022. The Company also highlighted PADCEV (enfortumab vedotin-ejfv), TUKYSA (tucatinib), ADCETRIS (brentuximab vedotin) and TIVDAK (tisotumab ...

/PRNewswire/ -- The Guarantors of EQIPD e.V. (GoEQIPD) announce the formation of a registered association, based in Heidelberg Germany, to host and to ensure...

Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results License option agreement with Novartis for target-specific access... | March 8, 2022

Medicenna Announces Peer-Reviewed Publication of Preclinical Data on MDNA11 in the Journal for ImmunoTherapy of Cancer -- MDNA11 demonstrates a 30-fold increase in affinity for... | January 26, 2022

The UK Government has ordered around 100,000 doses of Xevudy (sotrovimab) from GlaxoSmithKline.

The UK Government has ordered around 100,000 doses of Xevudy (sotrovimab) from GlaxoSmithKline.

The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the EQIPD Innovative Medicines Initiative (IMI) project.

Breaking news headlines about Breast Cancer linking to 1,000s of websites from around the world